These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7043421)

  • 21. [Chronic hepatitis: value of clinical and biological features in its differentiation].
    Antón Aranda E; López García C; Martí Cabané J; Tiberio López G
    Rev Esp Enferm Apar Dig; 1986 Dec; 70(6):503-6. PubMed ID: 3563013
    [No Abstract]   [Full Text] [Related]  

  • 22. Portal venous "goodies" and fulminant viral hepatitis.
    Sherlock S
    N Engl J Med; 1976 Dec; 295(27):1535-6. PubMed ID: 995164
    [No Abstract]   [Full Text] [Related]  

  • 23. [My journey to explore the reproductive medicine for intractable liver disease].
    Okita K
    Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):537-43. PubMed ID: 15920949
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppressive therapy in active chronic hepatopathies].
    Buligescu L; Ciontea M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(3):241-56. PubMed ID: 30138
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of glucagon and insulin on poly(ADP-ribose) polymerase activity and blood ketone body ratio after partial hepatectomy in rats].
    Kawamura M; Sudo T; Fujii Y; Fukunishi K; Yasuda C; Tsubakimoto R; Miyamoto M; Shobu R; Kuyama T
    Nihon Geka Hokan; 1989 Jan; 58(1):119-25. PubMed ID: 2508588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphological characteristics of the manifestation of chronic hepatitis and cirrhosis of viral etiology in chronic alcoholics].
    Shabanov AM; Domanin AA; Ivanov AA; Lubashevskiĭ VT; Shlinchak NV
    Ter Arkh; 1987; 59(7):25-8. PubMed ID: 3672354
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 28. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2583-91. PubMed ID: 16279916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential drug delivery for liver diseases.
    Huang X; Lee F; Teng Y; Lingam CB; Chen Z; Sun M; Song Z; Balachander GM; Leo HL; Guo Q; Shah I; Yu H
    Adv Drug Deliv Rev; 2019; 149-150():72-84. PubMed ID: 31734169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stimulation of hepatic regeneration].
    Oka H
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):785-8. PubMed ID: 6387011
    [No Abstract]   [Full Text] [Related]  

  • 32. [New trends in the therapy of alcoholic hepatic diseases].
    Tarantino G; Di Bernardo C; Vitaglione R; Cambri S
    Clin Ter; 1984 May; 109(3):243-58. PubMed ID: 6203679
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute hepatic failure, with special reference to its treatment].
    Takahashi Y
    Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1079-96. PubMed ID: 6757344
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatology at the turn of centuries].
    Nogaller AM
    Klin Med (Mosk); 2002; 80(9):13-7. PubMed ID: 12416218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytofluorimetric study of glycogen fractions of the liver cells of patients with chronic viral and alcoholic hepatitis].
    Kudriavtseva MV; Skorina AD; Smirnova SA; Deĭneka ZG; Kudriavtsev BN
    Tsitologiia; 1988 Jun; 30(6):705-9. PubMed ID: 3176178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 37. Automated data sampling in sections from selected liver diseases.
    Simon H; Kranz D; Voss K; Wenzelides K
    Pathol Res Pract; 1980 Dec; 170(4):388-401. PubMed ID: 7012815
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in poly (ADP-ribose) polymerase activity in post-hepatectomized rat liver nuclei with glucagon and insulin].
    Fujii Y
    Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):385-95. PubMed ID: 2505048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcoholic hepatitis: clinicopathologic features and therapy.
    Maddrey WC
    Semin Liver Dis; 1988 Feb; 8(1):91-102. PubMed ID: 2834829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute alcoholic hepatitis: treatments].
    Naveau S
    Presse Med; 2001 Jun; 30(20):1024-30. PubMed ID: 11433695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.